We have recently been contacted by the CEO of an Australian startup called DeepMeds. Their solution is a deep-learning-based software that reduces the use of contrast agents by at least 80% and generates images with higher contrast than an image with a full dose injection (see their pitch deck attached).
They would like to connect with Radiologists to present his innovation and see if there’s an opportunity to do clinical validation, as their product needs more data points to validate the AI, and they need to understand how it would operate in a clinical environment.
Is this something that would interest you? Please let me know and I can make a connection. Please feel free to forward this email to your colleagues if you think it would interest others too.
DeepMeds startup Pitch.pdf (7.4 MB)